BlueRock Therapeutics

BlueRock Therapeutics is an engineered cell therapy company that develops regenerative medicines for intractable diseases. BlueRock's CELL+GENE platform is used to direct cellular differentiation and genetically engineer cells to create a new generation of cellular medicines in the areas of neurology, cardiology, and immunology.

TypeSubsidiary
Parent CompanyBayer
HQCambridge, US
Founded2016
Websitebluerocktx.com
BlueRock Therapeutics was founded in 2016 and is headquartered in Cambridge, US

Viewing summary data as a guest

Sign up for free to see all data

BlueRock Therapeutics Office Locations

BlueRock Therapeutics has offices in Cambridge, New York and Toronto
Cambridge, US (HQ)
1 Broadway
New York, US
36 E 31st Street, Suite 602
Toronto, CA
101 College Street, East Tower
Show all (3)

BlueRock Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2016

Total Funding

$225 m

Investors

In total, BlueRock Therapeutics had raised $225 m. BlueRock Therapeutics is a subsidiary of Bayer

BlueRock Therapeutics Online and Social Media Presence

Embed Graph

BlueRock Therapeutics Frequently Asked Questions

  • When was BlueRock Therapeutics founded?

    BlueRock Therapeutics was founded in 2016.

  • Who are BlueRock Therapeutics competitors?

    Competitors of BlueRock Therapeutics include ACADIA Pharmaceuticals, Sangamo BioSciences and Regenxbio.

  • Where is BlueRock Therapeutics headquarters?

    BlueRock Therapeutics headquarters is located at 1 Broadway, Cambridge.

  • Where are BlueRock Therapeutics offices?

    BlueRock Therapeutics has offices in Cambridge, New York and Toronto.

  • How many offices does BlueRock Therapeutics have?

    BlueRock Therapeutics has 3 offices.